SCHEMBL19748971

SCHEMBL19748971

CCCCOCCOc1ccccc1-c1ccc2c(c1)/C=C(/C(=O)O)CCCN2CCCC

nearest known ligand 0.46

Predicted protein targets (top 16)

geneUniProtsupporting neighboursconfidence
CCR5 P51681 10/20 0.46
KDM4E B2RXH2 6/20 0.43
ALDH1A1 P00352 4/20 0.43
TDP1 Q9NUW8 2/20 0.43
MEN1 O00255 2/20 0.43
KMT2A Q03164 2/20 0.43
CCR2 P41597 2/20 0.43
CCR7 P32248 1/20 0.43
RARB P10826 1/20 0.42
SMN1; SMN2 Q16637 1/20 0.42
CCR3 P51677 1/20 0.41
CCR4 P51679 1/20 0.41
LMNA P02545 1/20 0.39
POLB P06746 1/20 0.39
L3MBTL1 Q9Y468 1/20 0.39
PPARG P37231 1/20 0.39

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL17870855 0.87 CCR5 (0.58) CCR5CCR2CCR7RARBCCR3
SCHEMBL17870854 0.87 CCR5 (0.58) CCR5CCR2CCR7RARBCCR3
SCHEMBL17870850 0.84 CCR5 (0.52) CCR5CCR2CCR7RARBCCR3
SCHEMBL17870851 0.84 CCR5 (0.52) CCR5CCR2CCR7RARBCCR3
SCHEMBL3458880 0.84 CCR5 (0.61) CCR5KDM4EALDH1A1MEN1KMT2A
SCHEMBL3458877 0.84 CCR5 (0.61) CCR5KDM4EALDH1A1MEN1KMT2A
SCHEMBL3458608 0.81 CCR5 (0.61) CCR5KDM4EALDH1A1MEN1KMT2A
SCHEMBL3458607 0.81 CCR5 (0.61) CCR5KDM4EALDH1A1MEN1KMT2A
SCHEMBL3458606 0.81 CCR5 (0.61) CCR5KDM4EALDH1A1MEN1KMT2A
SCHEMBL3458969 0.79 CCR5 (0.56) CCR5KDM4EALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3471718-A1 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC Tobira Therapeutics, Inc. (US) 2019-04-24 EP disclosed
WO-2017223155-A1 PURIFIED CENICRIVIROC AND PURIFIED INTERMEDIATES FOR MAKING CENICRIVIROC TOBIRA THERAPEUTICS, INC. (US) 2017-12-28 WO disclosed